Inspiration Biopharmaceuticals develops treatments for hemophilia. A regulatory filing shows the company has raised its latest funding to $247.6M. The filing describes a package of financing that includes a new outside equity investment, non‑equity exchanged for equity, an exchange of prior equity for new equity, and convertible notes tied to future milestones convertible into equity. The filing also grants an investor a right to buy the firm, though the company says a business combination is not imminent but may arise in connection with the funding. The current fundraising effort is targeted at $371.6M. The company was co‑founded by John Taylor (of FX Concepts) and Scott Martin (of Martin Midstream Partners and Martin Resource Management Corp.), and the filing notes their children both suffer from hemophilia.

Total raised

$248M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2011